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Introduction {#sec1}
============

SLX4 coordinates a multiprotein complex that is important for DNA repair. In metazoans, this complex includes three structure-selective nucleases: XPF-ERCC1, MUS81-EME1, and SLX1 ([@bib2; @bib13; @bib26; @bib30; @bib36]). Together these nucleases confer the complex with the ability to cleave a wide range of branched DNA structures in vitro, which mimic DNA intermediates that occur during the repair of damaged DNA and broken DNA replication forks. Both MUS81-EME1 and XPF-ERCC1 are required for the repair of DNA interstrand crosslinks (ICLs) in mammalian cells, and the latter is also required for repair of UV-induced lesions ([@bib9]). Depletion of SLX4 from human cells using siRNA duplexes does not affect UV repair but causes pronounced hypersensitivity to agents that induce DNA ICLs ([@bib13; @bib26; @bib36]). The importance of SLX4 in ICL repair in humans is underscored by the observation that biallelic mutations in SLX4/FANCP cause Fanconi anemia (FA) ([@bib20; @bib35]), a cancer predisposition syndrome accompanied by developmental, skeletal, and hematological defects ([@bib3]).

Despite the clear importance of the SLX4 complex in DNA repair, little is known about the underlying molecular mechanisms. For example, it is not yet known if SLX1 is involved in ICL repair, partly because depletion of SLX1 from human cells destabilized SLX4, preventing the functional analysis of SLX1 ([@bib26]). Furthermore, it is not yet known how SLX4 affects the associated nucleases, and there has been some debate about whether the exquisite hypersensitivity of SLX4-defective cells reflects the loss of regulation of one or more of these nucleases. In this light, a recent study concluded that the role of SLX4 in ICL repair involves XPF-ERCC1 only, because a fragment of SLX4 lacking amino acids 1--499, that did not interact with XPF-ERCC1, did not rescue the mitomycin-C (MMC) sensitivity of *Slx4* hypomorphic MEFs ([@bib10]). However, the first 499 amino acids of SLX4 also contain two ubiquitin-binding domains that are vital for ICL repair but that are not required for SLX4 to interact with XPF ([@bib20; @bib35]). Two studies used SLX4 deletion mutants lacking the C-terminal helix-turn-helix (HtH) domain to investigate the importance of SLX1 binding for ICL repair. One study found that the HtH deletion mutant fully rescues the sensitivity of *Slx4* hypomorphic MEFs ([@bib10]), whereas the other showed that this mutant only partly rescued the MMC sensitivity of SLX4-defective FA cells ([@bib21]). Therefore, the functional relevance of the binding of nucleases to SLX4 in ICL repair remains unclear.

The SLX4 complex is capable of processing Holliday junctions (HJs) in vitro ([@bib13; @bib26; @bib36]). HJs are four-way DNA junctions at which two chromatids are topologically intertwined. These structures arise during homologous recombination (HR), a process required for repairing unscheduled double-strand breaks (DSBs) or damaged replication forks in mitotic cells. HJs are also key intermediates during meiotic recombination ([@bib32; @bib40]). Ultimately HJs must be removed to enable chromosome segregation, and two distinct modes of HJ removal have been identified in mammalian cells ([@bib32]). The first pathway involves the dissolution of double HJs (dHJs) by the BTR complex (BLM-TOPIII-RMI1-RMI2). The coupled helicase and topoisomerase activities of BLM and TOPIII, respectively, disassemble HJs, resulting exclusively in noncrossover products ([@bib7; @bib42; @bib43]). This pathway dominates in mitotic cells, possibly because minimizing crossovers lowers the incidence of loss of heterozygosity (LOH) that would increase disease risk and impair organism fitness ([@bib23]).

Alternatively, HJs can be resolved by nucleases ([@bib32; @bib40]). Depending on the symmetry of the cleavage, crossover or noncrossover products may occur. Cells from Bloom syndrome (BS) patients lacking BLM show a large increase in the frequency of sister chromatid exchanges (SCEs), which are thought to result from the crossovers generated by nucleolytic resolution of dHJs that escape dissolution ([@bib7; @bib39]). To date, three nuclear HJ resolving activities have been identified in mammalian cells: MUS81-EME1, SLX1, and GEN1 ([@bib4; @bib13; @bib19; @bib26; @bib36; @bib37; @bib39; @bib40]). GEN1 cleaves HJs symmetrically to produce nicked linear duplex products ([@bib19; @bib29]), whereas SLX1 introduces a mixture of symmetric and asymmetric cuts across the junction ([@bib13; @bib26; @bib36]). In contrast to GEN1 and SLX1, MUS81-EME1 does not cleave intact HJs efficiently, but prefers nicked junctions and recombination intermediates such as extended D-loop structures ([@bib6; @bib8; @bib12; @bib14; @bib41]).

The elevated SCE frequency in BS cells requires GEN1 and MUS81-EME1 ([@bib39]). However, although GEN1 cleaves intact HJs efficiently in vitro, MUS81-EME1 does not. Instead MUS81-EME1 shows a strong preference for nicked HJs, suggesting that it might act on junctions that are subjected to prior nicking by a different nuclease. One possible candidate is SLX1 because it can process intact HJs efficiently in vitro. Furthermore, SLX1 and MUS81-EME1 bind to the HtH motif and the SAP domain of SLX4, respectively ([@bib13; @bib21; @bib36]). The close proximity of the SLX4 SAP and HtH domains places SLX1 close enough to MUS81-EME1 on SLX4 to suggest the possibility of cooperation between the two nucleases. In this sense, one function of SLX4 in its capacity as a scaffold would be to facilitate serial processing of HJs, a possibility raised previously ([@bib36]). In this study, we investigated whether SLX1 is involved in HJ resolution and ICL repair, and we tested potential cooperation with MUS81-EME1 and the functional significance of binding of these nucleases to SLX4.

Results {#sec2}
=======

Disruption of the Murine *Giyd2/Slx1* and *Btbd12/Slx4* Genes {#sec2.1}
-------------------------------------------------------------

There is currently no information on SLX1 function in mammals. To study the in vivo roles of SLX1, we disrupted the murine *Giyd2* (*Slx1*) gene by eliminating the transcription start site and the remainder of the first exon ([Figure S1](#app2){ref-type="sec"}A). Gene disruption was confirmed by Southern blotting and PCR ([Figures S1](#app2){ref-type="sec"}B and S1C). Both *Slx1*^+/−^ and *Slx1*^−/−^ mice were born at Mendelian frequencies ([Table S1](#app2){ref-type="sec"}) without overt morphological, developmental, or hematological defects. Adult mice were fertile (data not shown). SLX1 protein was undetectable in extracts of *Slx1*^−/−^ mouse embryonic fibroblast extracts (MEFs) ([Figure 1](#fig1){ref-type="fig"}A) or testis extracts ([Figure S1](#app2){ref-type="sec"}D) by western blotting. The expression levels of SLX4, ERCC1, and MUS81 proteins, however, were normal in *Slx1*^−/−^ MEFs ([Figure 1](#fig1){ref-type="fig"}A).

We also disrupted the murine *Btbd12* (*Slx4*) gene ([Figure S2](#app2){ref-type="sec"}A); gene disruption was confirmed by Southern blotting, PCR ([Figures S2](#app2){ref-type="sec"}B and S2C), and western blotting ([Figure S2](#app2){ref-type="sec"}D). The expression levels of SLX4-associated proteins ERCC1 and MUS81 were normal in MEFs from the *Slx4*^−/−^ mice but SLX1 protein was undetectable by western blotting ([Figure 1](#fig1){ref-type="fig"}A). This suggests that SLX4 regulates SLX1 protein stability, and therefore SLX4 null mice lack both SLX1 and SLX4 proteins. Initially, no viable *Slx4*^−/−^ offspring were obtained from crossing *Slx4* heterozygotes. However, after backcrossing the heterozygotes five times, we obtained viable *Slx4*^−/−^ mice, albeit at sub-Mendelian frequencies ([Table S2](#app2){ref-type="sec"}). *Slx4*^−/−^ mice were on average around 10%--15% smaller than heterozygotes or wild-type mice at the age of 6 weeks (data not shown). No overt developmental or morphological defects were observed. Although mating *Slx4*^−/−^ males with *Slx4*^−/−^ females resulted in viable progeny, testes in males were on average 47% smaller than in wild-type mice at 10 weeks of age (data not shown). Smaller testis size is in line with two previous reports describing a hypomorphic *Slx4* mouse strain made by the European Conditional Mouse Mutagenesis Program (EUCOMM) ([@bib10; @bib18]). It is worth noting that the EUCOMM mice were reported to exhibit phenotypes reminiscent of those seen in FA patients such as aplastic anemia ([@bib10]), even though mouse knockouts of other FA genes did not recapitulate most of these phenotypes ([@bib5]). However, we saw no evidence of an FA-like syndrome in the *Slx4*^*−/−*^ or *Slx1*^*−/−*^ mice we generated in this study (data not shown).

SLX1 Nuclease Activity Is Required for Repair of DNA ICLs {#sec2.2}
---------------------------------------------------------

We next investigated if SLX1 is involved in ICL repair assessed by hypersensitivity to genotoxins that induce ICLs. As shown in [Figure 1](#fig1){ref-type="fig"}B, *Slx1*^−/−^ MEFs are hypersensitive to ICL-inducing agents such as nitrogen mustard (HN-2) and MMC, and embryonic stem cells (ESCs) from *Slx1*^−/−^ mice were also hypersensitive to MMC ([Figure S3](#app2){ref-type="sec"}A). The sensitivity of *Slx1*^−/−^ MEFs to agents that induce ICLs was much less pronounced than *Slx4*^−/−^ MEFs, probably because SLX4 binds to several nucleases involved in ICL repair in addition to SLX1. *Slx1*^−/−^ MEFs and ESCs were not more sensitive to camptothecin (CPT), ionizing radiation (IR), hydroxyurea (HU), or UV light than wild-type cells ([Figures S3](#app2){ref-type="sec"}A and S3B). Defects in the repair of ICLs often result in chromosome abnormalities ([@bib3]). In this light, we observed a slight increase in the number of chromosome abnormalities such as chromatid breaks and radial structures in *Slx1*^−/−^ MEFs exposed to MMC compared with wild-type cells, and a much larger increase in *Slx4*^−/−^ MEFs ([Figure S3](#app2){ref-type="sec"}C).

We next tested if the nuclease activity of SLX1 is required for cellular resistance to ICL-inducing agents. To this end we mutated a highly conserved residue, Glu79, in the SLX1 URI-type nuclease domain to alanine. This mutation abolished the activity of FLAG-tagged mouse SLX1 immunoprecipitated from HEK293 cells in the cleavage of a radioactively \[5′-^32^P\]-labeled HJ with a core that could undergo a number of steps of branch migration, thereby presenting all possible dinucleotides at the point of exchange ([Figure 1](#fig1){ref-type="fig"}C) ([@bib26]). Next, *Slx1*^−/−^ MEFs were infected with viruses expressing untagged SLX1 wild-type or E79A, or with empty virus; mutation of E79 in SLX1 did not affect interaction with SLX4 ([Figure 1](#fig1){ref-type="fig"}D). As shown in [Figure 1](#fig1){ref-type="fig"}E, wild-type SLX1, but not the E79A mutant, rescued the MMC hypersensitivity of *Slx1*^−/−^ MEFs. Together, these data provide evidence that SLX1 is involved in repair of DNA ICLs in mammals.

SLX1 Is Required for the Nucleolytic Processing of HJs {#sec2.3}
------------------------------------------------------

SLX1 is capable of processing HJs in vitro ([@bib13; @bib26; @bib36]). We next investigated whether SLX1 is required for HJ resolution in vivo using the elevated SCE frequency observed in BLM-depleted cells as readout ([Figure 2](#fig2){ref-type="fig"}A). To this end, we used shRNA-expressing retroviruses to deplete BLM from *Slx1*^−/−^ MEFs ([Figure S4](#app2){ref-type="sec"}A) ([@bib34]). As shown in [Figure 2](#fig2){ref-type="fig"}B, BLM protein was undetectable in MEF extracts when cells were infected with retrovirus expressing the BLM shRNA, but not when empty virus was used. Depletion of BLM from wild-type MEFs caused an increase in SCE frequency from 8.3 SCE per metaphase to 18 SCE per metaphase ([Figure 2](#fig2){ref-type="fig"}C), but in two separate clones of *Slx1*^−/−^ MEFs, the SCE frequency after BLM depletion was diminished to around 12 SCE per metaphase. A similar defect in SCE was observed in *Slx4*^−/−^ MEFs ([Figure 2](#fig2){ref-type="fig"}C), in agreement with a previous analysis of BS cells depleted of SLX4 ([@bib39]). The SCE defect in *Slx1*^−/−^ MEFs depleted of BLM was rescued by expression of wild-type SLX1 but not by the nuclease-inactive SLX1 E79A mutant ([Figure 2](#fig2){ref-type="fig"}D). Therefore, SLX1 is required for nucleolytic resolution of HJs in vivo.

We also analyzed SCEs formed during the repair of ICLs. Exposure of wild-type MEFs to MMC caused a dose-dependent increase in SCE frequency, but *Slx1*^−/−^ MEFs were indistinguishable from wild-type cells in this regard ([Figures 2](#fig2){ref-type="fig"}E and 2F). In contrast, the MMC-induced increase in SCE frequency was reduced by more than 30% in *Slx4*^−/−^ MEFs ([Figures 2](#fig2){ref-type="fig"}E and 2F). Thus, although SLX4 contributes to the generation of SCE during ICL repair, SLX1 does not appear to be involved. This could be due, in principle, to redundancy between SLX1 and nucleases such as MUS81-EME1, as discussed below.

SLX1 Is Epistatic with MUS81-EME1 in ICL Repair and HJ Resolution {#sec2.4}
-----------------------------------------------------------------

The phenotypes associated with disruption of *Slx1* in mice described above are somewhat reminiscent of those reported for *Mus81*^−/−^ mice ([@bib11]). In both cases, the mice are viable and fertile with no gross abnormalities, but MEFs are hypersensitive to ICL-inducing agents. Cells from both mice also show a higher than normal level of chromosome abnormalities after exposure to MMC. These observations, together with the physical proximity of SLX1 and MUS81-EME1 bound to SLX4, suggest that these two nucleases might act in the same pathway, perhaps cooperatively. In order to test this possibility, we generated *Slx1*^−/−^ *Mus81*^−/−^ double knockout mice to enable epistasis analysis. These mice were born at Mendelian frequencies ([Table S3](#app2){ref-type="sec"}), showing no developmental, morphological, or hematological abnormalities. Moreover, the fertility of *Slx1*^−/−^, *Mus81*^−/−^, or *Slx1*^−/−^ *Mus81*^−/−^ littermates, or testis size in males, is not significantly different from wild-type mice (data not shown). To study HJ resolution, we isolated MEFs from *Slx1*^−/−^ *Mus81*^−/−^ embryos, and as control we used MEFs from single knockout embryos (*Slx1*^−/−^ *Mus81*^+/−^ and *Slx1*^+/−^ *Mus81*^−/−^). Double heterozygous (*Slx1*^+/−^ *Mus81*^+/−^) embryos were used as negative control ([Figure S4](#app2){ref-type="sec"}B).

As mentioned earlier, SLX1 had no effect on SCEs generated in MEFs exposed to MMC ([Figures 2](#fig2){ref-type="fig"}E and 2F), and similar data were reported for *Mus81*^−/−^ cells ([@bib24]). However, it was possible this is because SLX1 acts redundantly with MUS81-EME1. However, as shown in [Figure 3](#fig3){ref-type="fig"}A, the increase in SCE frequency induced by MMC in cells lacking both MUS81 and SLX1 was indistinguishable from control cells (*Slx1*^+/−^ *Mus81*^+/−^) and the *Slx1*^−/−^ or *Mus81*^−/−^ single knockouts. We also compared the MMC sensitivity of *Slx1*^−/−^ *Mus81*^−/−^ MEFs with the respective single knockouts in clonogenic survival assays. As shown in [Figures 3](#fig3){ref-type="fig"}B, the MMC hypersensitivity of *Mus81*^−/−^ cells was slightly more pronounced than *Slx1*^−/−^ cells, and *Slx1*^−/−^ *Mus81*^−/−^ cells were not more sensitive than the most sensitive of the single knockouts (*Mus81*^−/−^). Similar results were obtained using alternative clones of MEFs ([Figure S4](#app2){ref-type="sec"}C). Taken together, these observations suggest that SLX1 and MUS81-EME1 are epistatic in terms of ICL repair, at least judged by hypersensitivity to MMC, but they are not required for SCE induced by ICLs in MEFs.

We went on to explore the possibility that SLX1 and MUS81-EME1 are also epistatic in the resolution of HJs. To this end, we depleted BLM from MEFs of various genotypes using shRNA-expressing retroviruses ([Figure 3](#fig3){ref-type="fig"}C). Depletion of BLM from control MEFs caused an increase in SCE frequency from around 7 SCE per metaphase to around 20 SCE per metaphase. In *Slx1*^−/−^ or *Mus81*^−/−^ single knockout MEFs, the SCE frequency after BLM depletion was diminished to around 10 SCE per metaphase, and no further decrease was observed in *Slx1*^−/−^ *Mus81*^−/−^ double knockout cells leaving the residual levels of SCE unaffected ([Figure 3](#fig3){ref-type="fig"}D). Therefore, SLX1 and MUS81-EME1 are epistatic with regard to the resolution of HJs that escape dissolution, suggesting that they function in the same pathway.

SLX4 Mutations that Prevent Interaction with SLX1 and/or MUS81-EME1 {#sec2.5}
-------------------------------------------------------------------

The data above suggest that SLX1 and MUS81-EME1 act together in HJ resolution, and we next set out to test if this requires the tethering of the two nucleases to SLX4 where they bind close together. The SLX1-interacting region of SLX4 has been localized to a small C-terminal fragment containing the HtH motif ([Figure 4](#fig4){ref-type="fig"}A) ([@bib13; @bib36]). A 200 amino acid fragment containing the HtH domain was subjected to saturated mutagenesis, followed by reverse yeast two-hybrid screening in order to find SLX4 mutations that abolish interaction with SLX1 (data not shown). Two such mutations were identified: a single point mutation in a highly conserved Cys residue in the SLX4 HtH domain (C1536R), and a small deletion mutant lacking six amino acids (Cys1536-Thr1541; [Figure 4](#fig4){ref-type="fig"}A). Full-length SLX4 bearing these mutations, or wild-type SLX4, was stably expressed in *Slx4*^−/−^ MEFs. As shown in [Figure 4](#fig4){ref-type="fig"}C, SLX1 is undetectable in extracts of *Slx4*^−/−^ MEFs, suggesting the stability of SLX1 requires that it binds to SLX4. Stable expression of wild-type SLX4 restored normal levels of SLX1 in *Slx4*^−/−^ MEFs. However, the SLX4 mutants C1536R or Δ1536-1541, expressed at levels similar to wild-type SLX4, did not restore SLX1 expression ([Figure 4](#fig4){ref-type="fig"}C). Furthermore, no SLX1 could be detected in SLX4 immunoprecipitates from cells expressing these mutant forms of SLX4, but MUS81 and ERCC1 were present at normal levels ([Figure 4](#fig4){ref-type="fig"}C). These data indicate that the interaction of SLX4 with SLX1 is required for SLX1 stability, and therefore cells expressing SLX4 mutants that cannot interact with SLX1 are essentially null for SLX1 expression. Nonetheless, these mutants can be used to investigate if SLX1 contributes to the roles of SLX4 in DNA repair.

We also set out to generate SLX4 mutants that cannot interact with MUS81-EME1. A previous study deleted the entire SAP domain of SLX4 to abolish interaction with MUS81-EME1, and the resulting SLX4 deletion fragment could only partly rescue the MMC sensitivity of FANCP cells ([@bib21]). However, even though in budding yeast Slx4 does not interact with Mus81-Mms4^Eme1^ ([@bib33]), we found that deleting the entire SAP domain of yeast Slx4 perturbs its function (data not shown). These data indicate that the SAP domain of yeast Slx4 is functionally important independent of MUS81 interaction, and it is likely that the same is true of human SLX4. On this basis we sought to engineer more subtle changes in mouse SLX4 that would abolish the interaction with MUS81-EME1. A fragment containing the SAP domain of SLX4 was subjected to saturated mutagenesis, reverse yeast two-hybrid and alanine scanning (data not shown). These experiments revealed several mutations in SLX4 that abolished interaction with MUS81-EME1: Y1340A, L1348A, and a combination of E1351A and L1352A ([Figure 4](#fig4){ref-type="fig"}B). Full-length SLX4 bearing these mutations, or wild-type SLX4, were stably expressed in *Slx4*^−/−^ MEFs. As shown in [Figure 4](#fig4){ref-type="fig"}D, the SLX4 Y1340A, L1348A, and E1351A L1352A mutants were unable to interact with MUS81-EME1 in coimmunoprecipitation experiments, but their ability to interact with SLX1 and ERCC1 was unaffected.

Binding of SLX1 and MUS81-EME1 to SLX4 Is Essential for HJ Resolution {#sec2.6}
---------------------------------------------------------------------

We next examined whether the SLX4 mutants that are unable to interact with SLX1 or MUS81-EME1 are able to rescue the defects observed in *Slx4*^−/−^ cells, starting with analysis of ICL repair. As shown in [Figure 5](#fig5){ref-type="fig"}A, the SLX4 C1536R and Δ1536-1541 mutants, that are incapable of interacting with SLX1, only partly rescued the MMC hypersensitivity of *Slx4*^−/−^ MEFs. The residual sensitivity of these cells was similar to that of *Slx1*^−/−^ cells ([Figure 1](#fig1){ref-type="fig"}B), consistent with a failure of C1536R and Δ1536-1541 SLX4 mutants to restore SLX1 expression in *Slx4*^−/−^ cells ([Figure 4](#fig4){ref-type="fig"}C). On the other hand, the SLX4 L1348A and E1351A L1352A mutants, both of which fail to interact with MUS81-EME1, were able to fully rescue the MMC hypersensitivity of *Slx4*^−/−^ MEFs ([Figure 5](#fig5){ref-type="fig"}B). Referring to the SLX4 C1536R mutant hereafter as SLX4^SLX1^ and the SLX4 E1351A L1352A as SLX4^MUS81^, we combined these mutations to generate SLX4^SLX1 MUS81^ ([Figure S5](#app2){ref-type="sec"}), and found that this compound mutant restored MMC hypersensitivity of *Slx4*^−/−^cells to the same degree as the SLX4^SLX1^ mutant ([Figure 5](#fig5){ref-type="fig"}C). These data suggest that MMC hypersensitivity of cells lacking SLX4 is at least partly due to lack of SLX1 and that the interaction of SLX4 with MUS81-EME1 is not required for ICL repair in MEFs.

We went on to test if the SLX4^SLX1^ and SLX4^MUS81^ mutants are defective in HJ resolution. As shown in [Figure 5](#fig5){ref-type="fig"}D, the elevation in SCE frequency triggered by BLM depletion is diminished in *Slx4*^−/−^ MEFs compared with wild-type MEFs. This defect is rescued by expression of wild-type SLX4, but not by the SLX4^SLX1^, SLX4^MUS81^ mutants or the SLX4^SLX1MUS81^ compound mutant. Therefore, it is likely that the binding of both SLX1 and MUS81-EME1 to SLX4 is essential for HJ resolution. In contrast, the binding of SLX1, but not MUS81-EME1, is important for ICL repair in MEFs ([Figure 5](#fig5){ref-type="fig"}C). These data suggested strongly that the role of SLX1 and MUS81-EME1 in ICL repair is independent of HJ resolution at least in cells from mice, and we set out to investigate this possibility.

An Hje-SLX1 Fusion Protein with a Preference for HJs {#sec2.7}
----------------------------------------------------

The data above show that SLX1 and MUS81-EME1 are both involved in HJ resolution, judged by measuring the increased SCE frequency caused by BLM depletion. However, SLX1 and MUS81-EME1 are both capable of cleaving a range of branched DNA structures besides HJs in vitro. This consideration, together with the observation that BLM can act on a similar range of branched substrates ([@bib25; @bib38]), raised the possibility that the SCEs in BLM-depleted cells arise from nucleolytic processing of structures other than four-way junctions. In an attempt to investigate this possibility, we set out to see if the cleavage of HJs by SLX1 and MUS81-EME1 is physiologically relevant. With this in mind, we mutated the SLX1 nuclease domain (R38A E79A) to inactivate it and fused this SLX1 derivative, which should maintain the ability to bind SLX4, to an archaeal resolving enzyme Hje. This enzyme was reported to have a marked preference for HJs compared with other resolvases ([@bib22]). We next asked if the resulting fusion protein, referred to as Hje-SLX1 ([Figure 6](#fig6){ref-type="fig"}A), can rescue defects associated with loss of SLX1. We used an analogous fusion construct containing a catalytically inactive D39A Hje mutant as a negative control. We confirmed that FLAG-tagged versions of the Hje-SLX1 fusion protein, and the catalytically inactive derivative, bind to SLX4 in coimmunoprecipitation experiments in HEK293 cells ([Figure S6](#app2){ref-type="sec"}B).

Next, anti-FLAG immunoprecipitates were incubated with radiolabeled DNA substrates. We used a four-way junction with a 12 bp homologous core (HJ), a replication fork (RF) analog (a three-way junction where one strand is discontinuous at the junction), and a 5′ flap. Reaction products were separated by gel electrophoresis under denaturing conditions. As shown in [Figure 6](#fig6){ref-type="fig"}B, both SLX1 and the Hje-SLX1 fusion exhibited strong cleavage activity on the four-way junction substrate. Consistent with previous reports, SLX1 cleaved the four-way junction at multiple positions ([@bib13; @bib26; @bib36]); the Hje-SLX1 fusion protein also cleaved at several points, but these were different from SLX1 ([Figure 6](#fig6){ref-type="fig"}B; [Figure S6](#app2){ref-type="sec"}A). Nonetheless, nondenaturing gel electrophoresis showed that Hje-SLX1 introduced symmetric cleavages within the homologous core of the HJ, resulting in the production of linear duplex DNA as required for the productive resolution of the junction ([Figure 6](#fig6){ref-type="fig"}C). The Hje-SLX1 derivative, which is inactivated by the D39A mutation, showed no detectable activity toward the HJ substrate ([Figure 6](#fig6){ref-type="fig"}B). Although all of the FLAG immunoprecipitates exhibited some nonspecific activity toward the RF substrate ([Figure 6](#fig6){ref-type="fig"}B, asterisk), a weak SLX1-specific cleavage product was observed in FLAG-SLX1 immunoprecipitates that was not present in SLX1 E79A precipitates ([Figure 6](#fig6){ref-type="fig"}B, arrowhead). This product was not observed in Hje-SLX1 precipitates, indicating that this fusion protein cannot cleave replication forks. The 5′ flap substrate was cleaved by FLAG-SLX1 one nucleotide before the junction, and by contrast, the Hje-SLX1 fusion exhibited only very weak activity three nucleotides from junction ([Figure 6](#fig6){ref-type="fig"}B; [Figure S6](#app2){ref-type="sec"}A). These experiments demonstrated that Hje-SLX1 binds to SLX4 and acts as a potent HJ resolving enzyme with restricted substrate specificity compared with SLX1.

HJs Are Physiological Substrates of SLX1 and MUS81-EME1 {#sec2.8}
-------------------------------------------------------

We next examined whether the Hje-SLX1 fusion could restore the cellular functions perturbed in cells lacking SLX1. Untagged versions of Hje-SLX1 and the inactive D39A derivative were stably expressed in *Slx1*^−/−^ MEFs ([Figure S6](#app2){ref-type="sec"}C, left panels). Cells were then depleted of BLM. Strikingly, the Hje-SLX1 fusion protein, but not the D39A version, restored SCE frequency in BLM-depleted *Slx1*^*−/−*^ MEFs similar to wild-type SLX1 ([Figure 6](#fig6){ref-type="fig"}D). Expression of Hje-SLX1 in cells that were not depleted of BLM had no apparent effect on SCE levels ([Figure 6](#fig6){ref-type="fig"}D). The Hje-SLX1 fusion and the inactive D39A derivative were also stably expressed in *Slx1*^−/−^ *Mus81*^−/−^ MEFs ([Figure S6](#app2){ref-type="sec"}C, right panels). This experiment revealed that Hje-SLX1 but not the D39A version restored SCE frequency after BLM depletion back to wild-type levels ([Figure 6](#fig6){ref-type="fig"}E). Taken together, these data strongly suggest that the formation of SCE in BLM-depleted cells, which was shown to require binding of SLX1 and MUS81-EME1 to SLX4, results from the resolution of HJs. Finally, we tested the ability of the Hje-SLX1 fusion protein to reverse the ICL repair defects in cells lacking SLX1. Intriguingly, the Hje-SLX1 fusion protein was incapable of rescuing the MMC hypersensitivity of *Slx1*^−/−^ MEFs in contrast to wild-type SLX1 ([Figure S6](#app2){ref-type="sec"}D). These data strengthen the notion that the role of SLX1 in ICL repair in MEFs involves cleavage of DNA structures other than HJs.

Discussion {#sec3}
==========

In this study, we demonstrate that SLX1 is involved in cellular responses to DNA damage in mammals. Consistent with its reported ability to process HJs in vitro ([@bib13; @bib26; @bib36]), we found that SLX1, like MUS81-EME1, plays a major role in the nucleolytic resolution of HJs in vivo. SLX1 and MUS81-EME1 are both required for resolving the majority of HJs that escape dissolution by BLM, and they act epistatically in this regard. We also found that the tethering of SLX1 and MUS81-EME1 to SLX4, where they bind in close proximity, is essential for the ability of these nucleases to promote HJ resolution. The simplest interpretation of these findings is that SLX1 and MUS81-EME1 act cooperatively in the processing of HJs, as previously postulated by others ([@bib36]). In this model SLX1 acts on intact HJs to create nicked junctions, which are then cleaved by MUS81-EME1 ([@bib6; @bib8; @bib12; @bib36; @bib41]). Close juxtaposition of SLX1 and MUS81-EME1 on SLX4 might position the respective active sites to favor coordinated first-strand cleavage by SLX1 and second-strand cleavage by MUS81-EME1. This idea might help to solve the longstanding dilemma of how MUS81-EME1 participates in HJ resolution in vivo when the recombinant enzyme only weakly cleaves intact HJs in vitro compared with nicked HJs ([@bib6; @bib8; @bib12; @bib41]).

The model whereby SLX1 and MUS81-EME1 act together in HJ resolution is based on measuring SCE frequency upon BLM depletion. But do the SCEs observed in BLM-depleted cells result from the cleavage of HJs? It is possible that the SCEs resulting from depletion of BLM reflect instead the cleavage of branched DNA structures other than HJs. This is a particular concern because BLM, like MUS81-EME1 and SLX1, is active toward a range of branched DNA structures in vitro ([@bib25; @bib38]). Furthermore, the cleavage of the precursors to HJs such as extended D-loop structures can produce crossovers that would manifest as SCEs ([@bib28]). Thus, it is possible that the SCEs in BLM-depleted cells occur as a result of the cleavage of recombination structures other than HJs. However, the demonstration that the Hje-SLX1 fusion protein with increased specificity for HJs can reverse the SCE defect in *Slx1*^−/−^ and *Slx1*^−/−^ *Mus81*^*−/−*^ cells strongly suggests that SCE formation in BLM-depleted cells reflects HJ cleavage by SLX1 and MUS81-EME1.

In this study we demonstrate that SLX1 is involved in ICL repair in mammalian cells, and similarly to HJ resolution, SLX1 appears to act epistatically with MUS81-EME1 in ICL repair. However, several observations suggest that the epistatic interaction between SLX1 and MUS81-EME1 in ICL repair does not involve the cleavage of HJs, at least in mice. First, the SCEs formed in MMC-treated MEFs do not require SLX1 or MUS81-EME1, unlike the SCEs observed in BLM-depleted cells. Second, whereas HJ resolution in BLM-depleted MEFs requires binding of both SLX1 and MUS81-EME1 to SLX4, cellular resistance to MMC requires binding of SLX1 but not MUS81-EME1. Third, the Hje-SLX1 fusion protein, which is much more specific for HJs than SLX1, can rescue the SCE defect in *Slx1*^*−/−*^ and *Slx1*^−/−^ *Mus81*^*−/−*^ MEFs depleted of BLM, but it cannot rescue the MMC hypersensitivity of these cells. These observations suggest that the role of SLX1 and MUS81-EME1 in the repair of ICLs involves the processing of structures other than HJs. How might SLX1 and MUS81-EME1 cooperate in ICL repair? MUS81-EME1 is known to act at the "unhooking" step of ICL repair, a process that involves incisions on either side of the ICL that produce DSBs ([@bib15; @bib16]). However, DSB induction in cells exposed to ICL-inducing agents does not require SLX1 (data not shown). Therefore, the epistatic interaction of SLX1 and MUS81-EME1 in ICL repair is independent of DSB induction. One possible explanation is that SLX1-SLX4 processes recombination intermediates during the repair of the DSBs generated by the pool of MUS81-EME1 that is not bound to SLX4.

It is clear that the dominant mode of HJ removal in mitotic cells---at least those arising spontaneously---involves BLM, and HJ resolution by nucleases acts to cleave junctions that escape dissolution. The BLM pathway has been supposed to minimize the risk of loss of heterozygosity, since this pathway generates noncrossover outcomes exclusively ([@bib23]). However, in meiotic cells crossover formation is necessary and should therefore involve nucleolytic HJ resolution. Since SLX1 and MUS81-EME1 resolve the majority of HJs that escape dissolution in mitotic mammalian cells, one might predict that they might dominate in meiosis. However, although *Mus81*^−/−^ mice show meiotic defects, they are fertile, suggesting that other nucleases can mediate HJ processing in the absence of MUS81-EME1 ([@bib11; @bib17]). This is unlikely to be SLX1, since the fertility and gonad size of *Slx1*^−/−^, *Mus81*^−/−^, or *Slx1*^−/−^ *Mus81*^−/−^ mice generated in this study were not significantly different from wild-type mice (data not shown). Since *Slx4*^−/−^ mice exhibit subfertility and hypogonadism, but *Slx1*^−/−^ *Mus81*^−/−^ do not, the third SLX4-associated nuclease, XPF-ERCC1, might be involved in meiotic HJ resolution. In this light, recent studies in nematodes found that XPF/BLM and SLX1/MUS81-EME1 act on parallel pathways in worm meiosis ([@bib1; @bib27; @bib31]). Moreover, SLX4 and XPF-ERCC1 are important for crossover generation in *Drosophila* ([@bib44]). It will be interesting to test if XPF-ERCC1 is involved in HJ resolution in mammals. However, since *Slx4*^−/−^ mice can generate offspring, it must be that nucleases that do not associate with SLX4 can resolve HJs in the absence of SLX4 complex components. This might be GEN1. It will be interesting to make the relevant combinations of gene knockouts in mice to investigate this. Given the importance of meiotic HJ resolution in heredity, and in preventing defects in chromosome segregation, it will be vitally important to decipher the precise mechanisms underlying the resolution of meiotic HJs.

Experimental Procedures {#sec4}
=======================

Depletion of BLM from MEFs Using shRNA {#sec4.1}
--------------------------------------

The protocol was adapted from a previous report ([@bib34]). Briefly, viruses expressing a BLM-specific shRNA were produced by cotransfecting 293T cells with pSUPER.retro.puro (Open Biosystems) expressing the BLM target sequence 5′-gga cct gct gga aga ttt a-3′ and with pCMV-VSV-G and pCMV-Gag-Pol. MEFs were infected four times in 6 hr intervals with virus-containing supernatant supplemented with 8 μg/ml polybrene. Twenty-four hours after the last infection, MEFs were selected with 3 μg/ml puromycin. Knockdown efficiency was confirmed by western blot.

SCE Assay {#sec4.2}
---------

Cells were treated for 24 hr with 10 μM BrdU before replacing the medium with fresh BrdU and the indicated dose of MMC for an additional 24 hr. When SCE analysis was performed after BLM knockdown, cells were selected for the uptake of virus in the presence of 3 μg/ml puromycin 24 hr after the last infection. MEFs were treated with two cycles of BrdU as described above ([Figure S4](#app2){ref-type="sec"}A). At 6 hr before the end of the second BrdU cycle, nocodazole was added at a final concentration of 0.15 μg/ml. Cells were harvested and prepared for metaphase spreads. Spreads were stained with Hoechst 33258, followed by UV irradiation and staining with Giemsa according to standard protocols. Fifty spreads were analyzed for each condition on a DeltaVision wide-field deconvolution microscope (Olympus).

Full details of all other experimental procedures are given in [Supplemental Information](#app2){ref-type="sec"}.
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![SLX1 Is Involved in the Repair of DNA ICLs\
(A) Western blot analysis of MEF extracts from wild-type (WT), *Slx1*^−/−^, and *Slx4*^−/−^ mice. Two separate *Slx1*^−/−^ MEF clones were tested. (See also [Figures S1](#app2){ref-type="sec"} and [S2](#app2){ref-type="sec"}.)\
(B) Clonogenic survival analysis of MEFs exposed to genotoxins. For each genotype, cell viability of untreated cells is defined as 100%. Data are represented as mean ± SEM, n = 3. (See also [Figure S3](#app2){ref-type="sec"}.)\
(C) HEK293 cells stably expressing tetracycline-inducible ("+") GFP-tagged mouse SLX4 were transfected with mouse SLX1 (WT), SLX1 active site mutant E79A, or left untransfected ("−"). Cell extracts were subjected to western blotting (left panel). Anti-FLAG immunoprecipitates were incubated with a synthetic radiolabeled four-way junction containing a 12 bp homologous core. Reaction products were subjected to denaturing PAGE (right panel).\
(D) Western blot analysis of *Slx1*^−/−^ MEFs complemented with untagged versions of wild-type SLX1, SLX1 E79A, or empty vector (top panels). Extracts were subjected to immunoprecipitation with anti-SLX4 antibodies, and precipitates were probed with the antibodies indicated (bottom panels). ^∗^, IgG light chain.\
(E) Clonogenic survival analysis of complemented *Slx1*^*−/−*^ MEFs from (D) exposed to increasing doses of MMC. For each genotype, cell viability of untreated cells was defined as 100%. Data are represented as mean ± SEM, n = 3.](gr1){#fig1}

![Defective HJ Resolution in *Slx1*^−/−^ Cells\
(A) Representative image of a metaphase spread for SCE analysis in MEFs after depletion of BLM with shRNA-expressing retroviruses. SCE events are indicated by arrowheads.\
(B) Western blot analysis of MEFs, of the genotypes indicated, infected with retroviruses expressing a BLM-specific shRNA (+) or with virus prepared with empty vector as control (−).\
(C) Scatterplot of SCE frequencies in MEFs depleted of BLM as described in (B). Fifty metaphases were analyzed for each condition, and significance was calculated using one-way ANOVA (^∗∗∗^p \< 0.0001) followed by Bonferroni's Multiple Comparison Test. Each point represents the total number of SCEs in a single mitotic spread. The horizontal line in each data set represents mean SCE frequency.\
(D) Same as (C) except that *Slx1*^−/−^ MEFs infected with viruses expressing SLX1, SLX1 E79A, or empty virus were analyzed. Significance was calculated as above; ^∗∗∗^p \< 0.0001; n.s., nonsignificant.\
(E) Scatterplot of SCE frequencies in wild-type, *Slx1*^−/−^, and *Slx4*^−/−^ MEFs after exposure to increasing concentrations of MMC. Fifty metaphases were counted for each condition. Each point represents the total number of SCEs in a single mitotic spread. The horizontal line in each data set represents mean SCE frequency.\
(F) Same as (E) except that the data were plotted as fold increase over untreated cells. Data are represented as mean ± SEM. Experimental significance was calculated using an unpaired t test; ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001.](gr2){#fig2}

![SLX1 and MUS81 Act Epistatically in HJ Resolution\
(A) Scatterplot of SCE frequencies in MEFs of the genotypes indicated after exposure to 10 ng/ml MMC. Fifty metaphases were counted for each condition and significance was calculated using a one-way ANOVA (^∗∗∗^p \< 0.0001) followed by Bonferroni's Multiple Comparison Test. Each point represents the total number of SCEs in a single mitotic spread. The horizontal line in each data set represents the mean SCE frequency.\
(B) Clonogenic survival analysis of MEFs of the genotypes indicated exposed to MMC. For each genotype, cell viability of untreated cells was defined as 100%. Data are represented as mean ± SEM, n = 3. (See also [Figure S4](#app2){ref-type="sec"}.)\
(C) Western blot analysis of MEFs, of the genotypes indicated, infected with retroviruses expressing a BLM-specific shRNA (+). Viruses prepared with empty vector served as control (−).\
(D) Cells from (C) were analyzed for SCE frequencies. Fifty metaphases were counted for each condition and significance was calculated as in (A). Each point represents the total number of SCEs in a single mitotic spread. The horizontal line in each data set represents mean SCE frequency.](gr3){#fig3}

![SLX4 Mutations that Prevent Interaction with SLX1 and MUS81\
(A) Alignment of the C terminus of SLX4 from different species. The HtH domain is highlighted in red. The black line above the alignment refers to the six amino acid deletion in SLX4 that abolished interaction with SLX1, and the asterisk indicates Cys1536. Jalpred3-based secondary structure prediction is indicated below the alignment with barrels representing α helices and the arrow a β sheet. M.m., *Mus musculus*; H.s., *Homo sapiens*; X.t., *Xenopus tropicalis*; G.g., *Gallus gallus*; D.r., *Danio rerio*; D.m., *Drosophila melanogaster*.\
(B) Alignment of the SAP domain of SLX4 from different species (highlighted in green). Tyr1340, Leu1348, Glu1351, and Leu1352 are indicated with asterisks. S.c., *Saccharomyces cerevisiae*; S.p., *Saccharomyces* pombe.\
(C) *Slx4*^−/−^ MEFs were infected with retroviruses expressing SLX4 wild-type (SLX4), SLX4 C1536R, or SLX4 Δ1536-1541. Extracts were subjected to western blot analysis (upper panels) or immunoprecipitation with anti-SLX4 antibodies (lower panels).\
(D) Same as (C) except that *Slx4*^−/−^ MEFs were infected with retroviruses expressing SLX4 wild-type (SLX4), SLX4 bearing alanine mutations at Y1340, L1348, or E1351+L1352.](gr4){#fig4}

![HJ Resolution Requires Binding of SLX1 and MUS81-EME1 to SLX4\
(A) Clonogenic survival analysis of *Slx4*^−/−^ MEFs stably expressing SLX4 wild-type (SLX4), SLX4 C1536R, or SLX4 Δ1536-1541, exposed to MMC. For each genotype, cell viability of untreated cells was defined as 100%. Wild-type MEFs and *Slx4*^−/−^ MEFs infected with empty virus were used as controls. Data are represented as mean ± SEM, n = 3.\
(B) Same as (A) except that SLX4 bearing alanine mutations at L1348 or E1351+L1352 were examined.\
(C) Clonogenic analysis as in (A) and (B) except that SLX4 mutations C1536R (SLX4^SLX1^) and E1351A+L1352A (SLX4^MUS81^) were combined to prevent interaction with both SLX1 and MUS81 (SLX4 ^SLX1MUS81^). (See also [Figure S5](#app2){ref-type="sec"}.)\
(D) Scatterplot of SCE frequencies in MEFs infected with retroviruses expressing a BLM-specific shRNA or control virus (−). The following MEFs were examined: *Slx4*^−/−^ MEFs infected with SLX4 wild-type or mutants of SLX4, i.e., SLX4^SLX1^, SLX4^MUS81^, or SLX4^SLX1MUS81^. Wild-type MEFs and *Slx4*^−/−^ MEFs infected with viruses prepared from empty vector were used as control. Fifty metaphases were counted for each condition and significance was calculated using one-way ANOVA (^∗∗∗^p \< 0.0001) followed by Bonferroni's Multiple Comparison Test. Each point represents the total number of SCE in a single mitotic spread. The horizontal line in each data set represents mean SCE frequency.](gr5){#fig5}

![HJs Are Physiological Substrates of SLX1 and MUS81\
(A) Schematic diagram of a Hje-SLX1 fusion protein. The SLX1 nuclease domain was mutated (R38A E79A) to inactivate it and fused to an archaeal resolving enzyme Hje known to cleave Holliday junctions preferentially.\
(B) HEK293 cells stably expressing GFP-tagged SLX4 were transfected with SLX1 wild-type or SLX1 E79A, Hje-SLX1, or Hje (D39A)-SLX1. Anti-FLAG immunoprecipitates were incubated with synthetic DNA structures: mobile Holliday junction (b strand-labeled Jbm5), replication fork (RF)-like structure (b strand-labeled), or 5′ flap (a3 strand-labeled). Reaction products were subjected to denaturing PAGE. Sequencing ladders were obtained by subjecting the corresponding substrates to Maxam and Gilbert's purine-specific reaction. Lower exposure is shown for the RF sequencing ladder. (See also [Figure S6](#app2){ref-type="sec"}.)\
(C) Same as (B) except the products from the HJ reaction were subjected to nondenaturing PAGE. HJ and duplex DNA (DS) of the same size as the predicted products of symmetrical cleavage of the HJ were run in parallel as markers.\
(D) Scatterplot of SCE frequencies in MEFs infected with retroviruses expressing a BLM-specific shRNA (+) or with control virus (−). The following MEFs were examined: *Slx1*^−/−^ MEFs infected with Hje-SLX1, Hje (D39A)-SLX1, or empty virus. Wild-type MEFs infected with empty virus were used as control. Fifty metaphases were counted for each condition and significance was calculated using one-way ANOVA (^∗∗∗^p \< 0.0001; n.s., nonsignificant) followed by Bonferroni's Multiple Comparison Test. Each point represents the total number of SCEs in a single mitotic spread. The horizontal line in each data set represents mean SCE frequency.\
(E) Same as (D) except that *Slx1*^−/−^*Mus81*^−/−^ MEFs expressing Hje-SLX1, Hje (D39A)-SLX1, or empty virus were examined.](gr6){#fig6}
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